The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis von Luah, Xiao Wen, Holst‐Hansen, Thomas, Lübker, Christopher

Volltext

The improved health utility of once‐weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1‐4 obesity trials von Bjorner, Jakob Bue, Larsen, Sara, Lübker, Christopher, Holst‐Hansen, Thomas

Volltext

Treatment effect of semaglutide 2.4 mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights von Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Holst‐Hansen, Thomas, Olivieri, Anamaria‐Vera, Manton, Andrew

Volltext

Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity von Wilkinson, Lua, Holst‐Hansen, Thomas, Laursen, Peter N., Rinnov, Anders R., Batterham, Rachel L., Garvey, W. Timothy

Volltext

Tipping-point transition from transient to persistent inflammation in pancreatic islets von Holst-Hansen, Thomas, Nielsen, Pernille Yde, Jensen, Mogens H., Mandrup-Poulsen, Thomas, Trusina, Ala

Volltext

Impact of Zygosity on Bimodal Phenotype Distributions von Holst-Hansen, Thomas, Abad, Elena, Muntasell, Aura, López-Botet, Miguel, Jensen, Mogens H., Trusina, Ala, Garcia-Ojalvo, Jordi

Volltext

The improved health utility of once‐weekly subcutaneous semaglutide 2.4mg compared with placebo in the STEP 1‐4 obesity trials von Jakob Bue Bjorner, Larsen, Sara, Lübker, Christopher, Thomas Holst‐Hansen

Volltext

Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial von Knop, Filip K, Aroda, Vanita R, do Vale, Ruben D, Holst-Hansen, Thomas, Laursen, Peter N, Rosenstock, Julio, Rubino, Domenica M, Garvey, W Timothy

Volltext

Once Daily Oral Semaglutide 50 mg Improves Physical Functioning in the OASIS 1 Trial von Rubino, Domenica, Holst-Hansen, Thomas, Karlsson, Tobias, Pietilainen, Kirsi, Traina, Andrea, Wharton, Sean, Wadden, Thomas

Volltext

Treatment effect of semaglutide 2.4mg on health‐related quality of life from STEP 1 SF‐6D derived from SF‐36 with Australian weights von Kral, Pavol, Allen, Felicity Liza, Larsen, Sara, Thomas Holst‐Hansen, Anamaria‐Vera Olivieri, Manton, Andrew

Volltext

Once-Daily Oral Semaglutide 50 mg Improves Cardiovascular Risk Factors in Overweight/Obesity von Garvey, W Timothy, Soborg, Thomas Holst-Hansen, Karlsson, Tobias, Hellerup, Filip Krag Knop, Copenhagen, Naveen Rathor, Rubino, Domenica, Rosenstock, Julio

Volltext

Impact of Oral Semaglutide 50 mg on Prediabetes According to Weight Loss Category: OASIS 1 Trial von Rosenstock, Julio, Frias, Juan, Garvey, W Timothy, Holst-Hansen, Thomas, Rinnov, Anders Rasmussen, Traina, Andrea, Knop, Filip Krag

Volltext

The Correlation Between Body Mass Index and Health-Related Quality of Life: Data from Two Weight Loss Intervention Studies von Kral, Pavol, Holst-Hansen, Thomas, Olivieri, Anamaria V., Ivanescu, Cristina, Lamotte, Mark, Larsen, Sara

Volltext

2-LB: Semaglutide 2.4 mg Reduces the 10-Year T2D Risk in People with Overweight/Obesity von TIMOTHY GARVEY, W., HOLST-HANSEN, THOMAS, LAURSEN, PETER N., RINNOV, ANDERS R., WILKINSON, LUA J.

Volltext

Spatiotemporal NF-κB dynamics encodes the position, amplitude, and duration of local immune inputs von Son, Minjun, Frank, Tino, Holst-Hansen, Thomas, Wang, Andrew G, Junkin, Michael, Kashaf, Sara S, Trusina, Ala, Tay, Savaş

Volltext

Impact of zygosity on bimodal phenotype distributions von Holst Hansen, Thomas, Abad Adan, Elena, Muntasell i Castellví, Aura, 1972, López-Botet, M. (Miguel), Jensen, Mogens, Trusina, Ala, García Ojalvo, Jordi

Volltext

260 - SEMAGLUTIDA 2,4 MG REDUCE EL RIESGO DE DIABETES MELLITUS TIPO 2 A 10 AÑOS EN PERSONAS CON SOBREPESO/OBESIDAD von de), Juana Carretero (en representación, Garvey, W. Timothy, Holst-Hansen, Thomas, Laursen, Peter N., Rinnov, Anders R., Wilkinson, Lua J.

Volltext

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial von Munch, Marie Warrer, Meyhoff, Tine Sylvest, Helleberg, Marie, Kjær, Maj‐Brit Nørregaard, Granholm, Anders, Hjortsø, Carl Johan Steensen, Jensen, Thomas Steen, Møller, Morten Hylander, Hjortrup, Peter Buhl, Wetterslev, Mik, Vesterlund, Gitte Kingo, Russell, Lene, Jørgensen, Vibeke Lind, Kristiansen, Klaus Tjelle, Benfield, Thomas, Ulrik, Charlotte Suppli, Andreasen, Anne Sofie, Bestle, Morten Heiberg, Poulsen, Lone Musaeus, Hildebrandt, Thomas, Knudsen, Lene Surland, Møller, Anders, Sølling, Christoffer Grant, Brøchner, Anne Craveiro, Rasmussen, Bodil Steen, Nielsen, Henrik, Christensen, Steffen, Strøm, Thomas, Cronhjort, Maria, Wahlin, Rebecka Rubenson, Jakob, Stephan M., Cioccari, Luca, Venkatesh, Balasubramanian, Hammond, Naomi, Jha, Vivekanand, Myatra, Sheila Nainan, Jensen, Marie Qvist, Leistner, Jens Wolfgang, Mikkelsen, Vibe Sommer, Svenningsen, Jens S., Laursen, Signe Bjørn, Hatley, Emma Victoria, Kristensen, Camilla Meno, Al‐Alak, Ali, Clapp, Esben, Jonassen, Trine Bak, Bjerregaard, Caroline Løkke, Østerby, Niels Christian Haubjerg, Jespersen, Mette Mindedahl, Abou‐Kassem, Dalia, Lassen, Mathilde Languille, Zaabalawi, Reem, Daoud, Mohammed Mahmoud, Abdi, Suhayb, Meier, Nick, Cour, Kirstine, Derby, Cecilie Bauer, Damlund, Birka Ravnholt, Laigaard, Jens, Andersen, Lene Lund, Mikkelsen, Johan, Jensen, Jeppe Lundholm Stadarfeld, Rasmussen, Anders Hørby, Arnerlöv, Emil, Lykke, Mathilde, Holst‐Hansen, Mikkel Zacharias Bystrup, Tøstesen, Boris Wied, Schwab, Janne, Madsen, Emilie Kabel, Gluud, Christian, Lange, Theis, Perner, Anders

Volltext

Synthetic Matrix Metalloproteinase Inhibitors Inhibit Growth of Established Breast Cancer Osteolytic Lesions and Prolong Survival in Mice von WINDING, Bent, NICAMHLAOIBH, Roisin, MISANDER, Henriette, HØEGH-ANDERSEN, Pernille, ANDERSEN, Thomas Levin, HOLST-HANSEN, Claus, HEEGAARD, Anne-Marie, FOGED, Niels Taekker, BRÜNNER, Nils, DELAISSE, Jean-Marie

Volltext

MCF7/LCC9 : An antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal ant... von BRÜNNER, N, BOYSEN, B, JIRUS, S, SKAAR, T. C, HOLST-HANSEN, C, LIPPMAN, J, FRANDSEN, T, SPANG-THOMSEN, M, FUQUA, S. A. W, CLARKE, R

Volltext